Anonymous
Guest
Anonymous
Guest
Good to know we've all got hookups in the auto sales and beeper kiosk businesses now!
What's next?
What's next?
So how does the AIT Labs and the Neura Therapeutik alliance enhance the other's business? Are the salespeople at Neura going to start selling compliance testing?
No one knows how it really is a benefit. Smoke and mirrors, maybe? Plus Neura doesn't actually make anything. They essentially deal with licensing drugs, etc.
NT is not a research Pharma Co. NT will take a generic compound ( oxycodone ), and put it in NT's delivery system and promote for a small window of time. Pharmacies wont stock b/c it is a branded generic and will have 3rd tier coverage meaning high copay to patients.I got that same impression about Neura Therapeutik after reviewing their website. Pretty vague and non-specific about what specific services or products they deliver. Whenever I see the word "partnering" as a primary description of what a company does I immediately become suspicious.
NT is not a research Pharma Co. NT will take a generic compound ( oxycodone ), and put it in NT's delivery system and promote for a small window of time. Pharmacies wont stock b/c it is a branded generic and will have 3rd tier coverage meaning high copay to patients.
Point of what? the partnership or the drugs?So what's the point?
It will help AIT only in Indiana and a few surrounding states. No PBM will put the drug on preferred formulary status over generic, looking at 3rd tier status. There is no way a physician write DSW on prescription pad.How does the partnership with NT help AIT's sales and overall revenue generation?
Lot of changes are coming 4th quarter.
What changes?
The blame game stops.
It will help AIT only in Indiana and a few surrounding states. No PBM will put the drug on preferred formulary status over generic, looking at 3rd tier status. There is no way a physician write DSW on prescription pad.
The blame game stops.